Newer Type 2 Diabetes Drugs Show Heart Protective Quality in Study

"The fact that the results are remarkably consistent from country to country regardless of which compound predominates, that certainly seems to suggest that it's a class effect," said Dr. Mikhail Kosiborod, a cardiologist from Saint Luke's Mid America Heart Institute.

"This class has a real potential of improving patient outcomes," Kosiborod said.

Read the full article, here.